🇺🇸 IV pantoprazole in United States
10 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 10
Most-reported reactions
- Blood Pressure Increased — 1 report (10%)
- Chest X-Ray Abnormal — 1 report (10%)
- Chills — 1 report (10%)
- Constipation — 1 report (10%)
- Crohn^S Disease — 1 report (10%)
- Dyspnoea — 1 report (10%)
- Faecal Calprotectin Increased — 1 report (10%)
- Heart Rate Increased — 1 report (10%)
- Infusion Related Reaction — 1 report (10%)
- Leukocytosis — 1 report (10%)
Other Gastroenterology approved in United States
Frequently asked questions
Is IV pantoprazole approved in United States?
IV pantoprazole does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for IV pantoprazole in United States?
Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.